Cargando…

Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis

There is increased concern that the quality, generalizability and reproducibility of biomedical research can be influenced by the sex of animals used. We studied the differences between male and female mice in response to invasive pulmonary mucormycosis including susceptibility to infection, host im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebremariam, Teclegiorgis, Alkhazraji, Sondus, Alqarihi, Abdullah, Wiederhold, Nathan P., Najvar, Laura K., Patterson, Thomas F., Filler, Scott G., Ibrahim, Ashraf S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072604/ https://www.ncbi.nlm.nih.gov/pubmed/33919611 http://dx.doi.org/10.3390/jof7040313

Ejemplares similares

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

2393. Evaluation of Antifungal Treatment in a Neutropenic Mouse Model of Scedosporiosis
por: Alkhazraji, Sondus, et al.
Publicado: (2018)

969. GRP78 and Integrin β1/α3 Play Disparate Roles in Epithelium Invasion During Mucormycosis
por: Alqarihi, Abdullah, et al.
Publicado: (2018)

119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis
por: Gu, Yiyou, et al.
Publicado: (2021)

APX001A Protects Immunosuppressed Mice from Rhizopus delemar Infection
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2017)

GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
por: Alqarihi, Abdullah, et al.
Publicado: (2020)

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
por: Alkhazraji, Sondus, et al.
Publicado: (2020)

LB1580. Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022)

Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Inhibition of EGFR Signaling Protects from Mucormycosis
por: Watkins, Tonya N., et al.
Publicado: (2018)

PCR-based Diagnosis of Mucormycosis Targeting Mucorales-specific Genes
por: Baldin, Clara, et al.
Publicado: (2017)

Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

678. Galactomannan Is a Biomarker of APX001 (Fosmanogepix) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022)

1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria
por: Youssef, Eman, et al.
Publicado: (2022)

Mucoricin is a Ricin-Like Toxin that is Critical for the Pathogenesis of Mucormycosis
por: Soliman, Sameh S. M., et al.
Publicado: (2021)

726. APX001 (Fosmanogepix) Is Effective in an Immunosuppressed Mouse Model of Rhizopus oryzae Infection
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

Mucormycosis in 2023: an update on pathogenesis and management
por: Alqarihi, Abdullah, et al.
Publicado: (2023)

Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
por: Youssef, Eman G., et al.
Publicado: (2020)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis
por: Wiederhold, Nathan P., et al.
Publicado: (2019)

1954. In vivo Efficacy of Delayed Therapy with the Novel Inositol Acyltransferase Inhibitor Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis
por: Wiederhold, Nathan P, et al.
Publicado: (2019)

The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection
por: Uppuluri, Priya, et al.
Publicado: (2018)

Invasive fatal rhino-orbito-cerebral mucormycosis in diabetic ketoacidosis
por: Garas, George, et al.
Publicado: (2010)

An integrated genomic and transcriptomic survey of mucormycosis-causing fungi
por: Chibucos, Marcus C., et al.
Publicado: (2016)

Neutropenic Enterocolitis due to Mucormycosis in a Patient with Myelodysplastic Syndrome
por: Park, Joon Woo, et al.
Publicado: (2020)

Case reports of invasive mucormycosis associated neutropenic enterocolitis in leukemic children: diagnostic and treatment challenges and review of literature
por: Amanati, Ali, et al.
Publicado: (2021)

97. A Cross-kingdom Vaccine Protects against Multiple Healthcare-associated Infections
por: Singh, Shakti, et al.
Publicado: (2022)

Rhino-orbito-cerebral mucormycosis in a child with diabetic ketoacidosis
por: Nayak, Snehamayee, et al.
Publicado: (2014)

Rhino-orbito-cerebral mucormycosis in a child with diabetic ketoacidosis
por: Kumar, M. Manoj, et al.
Publicado: (2014)

Radiological manifestation of optic nerve infarction in a patient with invasive mucormycosis secondary to diabetic ketoacidosis in Pakistan
por: Tabassum, Shehroze, et al.
Publicado: (2023)

In vitro Activity of Fosfomycin, Alone and Combined with Cefepime and Meropenem, Against Carbapenemase-Producing Gram-Negative Bacteria
por: Wiederhold, Nathan P, et al.
Publicado: (2017)

Isolated splenic mucormycosis secondary to diabetic ketoacidosis: a case report
por: Luo, Shuai, et al.
Publicado: (2022)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris
por: Singh, Shakti, et al.
Publicado: (2023)

Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus
por: Wiederhold, Nathan P., et al.
Publicado: (2019)

1724. Plasmid-free CRISPR-Cas9 System for Genetic Engineering of Rhizopus delemar
por: Gu, Yiyou, et al.
Publicado: (2019)

Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report
por: Monroig, Vanessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8fb567kqdn37bdhj66fqvlldh